DOCK8 (Q8NF50) variants and mutations
DOCK8 (also known as Q8NF50) is a human protein-coding gene encoding a dedicator of cytokinesis protein 8 protein. It coordinates actin remodeling and signaling required for migration, survival, and immune synapse formation in lymphocytes. Biallelic loss-of-function variants cause DOCK8 deficiency, a combined immunodeficiency characterized by severe viral infections, allergy, eczema, and malignancy risk. This analysis covers 3,055 DOCK8 variants and mutations. Of these, 76% have computational variant effect predictions. Disease context includes combined immunodeficiency due to DOCK8 deficiency, Autosomal recessive hyper-IgE syndrome, and hyper-IgE syndrome. Example DOCK8 variants include M1?, M1T, and A2T.
Variant analysis overview
- Gene: DOCK8
- Protein: Q8NF50
- UniProt accession: Q8NF50
- Organism: Homo sapiens
- Variants analyzed: 3055
- Variant scope: all variants
- Completed: 2026-08-21
Variant and mutation evidence
- Variant composition: 2,987 unspecified-consequence records; 43 missense variants; 19 synonymous variants; 1 stop-gained variants; 2 frameshift variants; 2 splice-region variants; 2 substitution
- Prediction scores: 2,323 variants have prediction scores (76% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: combined immunodeficiency due to DOCK8 deficiency, Autosomal recessive hyper-IgE syndrome, hyper-IgE syndrome, severe combined immunodeficiency, intellectual disability, autosomal dominant 2, squamous cell carcinoma, combined immunodeficiency, lymphoma, hereditary disease, immunodeficiency disease, hair color, autosomal dominant non-syndromic intellectual disability.
Protein structure and variant hotspots
- Protein features: 2 domains; 8 post-translational modification sites.
- Structural context: 781 variants have structural context.
- PTM context: 13 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable DOCK8 variants
Examples include M1?, M1T, A2T, A2V, A2S, A2A, T3S, T3T. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1?, NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- M1T (p.Met1Thr), rs760902978, ClinGen CA4956899, ClinVar RCV001364837, ClinVar RCV001824958, MetaLR 0.03, MetaSVM -1.05, Uncertain significance, not specified; Combined immunodeficiency due to DOCK8 deficiency
- A2T (p.Ala2Thr), rs995474571, ClinGen CA187758527, ClinVar RCV001341909, TOPMed rs995474571, AlphaMissense 0.79, MetaLR 0.03, Uncertain significance, Combined immunodeficiency due to DOCK8 deficiency
- A2V (p.Ala2Val), Ensembl rs2046705750, AlphaMissense 0.93, MetaLR 0.04
- A2S (p.Ala2Ser), gnomAD 9-214980-G-T, AlphaMissense 0.25, MetaLR 0.03
- A2A (p.Ala2Ala), rs759932577, gnomAD 9-214982-C-A, MetaLR 0.03, MetaSVM -1.07
- T3S (p.Thr3Ser), rs199739266, ClinGen CA4956902, ClinVar RCV006610061, 1000Genomes rs199739266, MetaLR 0.02, MetaSVM -1.01, Benign, Combined immunodeficiency due to DOCK8 deficiency
- T3T (p.Thr3Thr), gnomAD 9-214985-T-C, MetaLR 0.02, MetaSVM -1.04
- L4V (p.Leu4Val), gnomAD rs1237906578, AlphaMissense 0.15, MetaLR 0.06, Likely benign
- L4M (p.Leu4Met), gnomAD 9-214986-C-A, AlphaMissense 0.23, MetaLR 0.06
- L4L (p.Leu4Leu), rs753215803, gnomAD 9-214988-G-C, MetaLR 0.03, MetaSVM -1.06
- P5R (p.Pro5Arg), rs1018736787, ClinGen CA187758545, ClinVar RCV002643841, ClinVar RCV005824474, AlphaMissense 0.49, MetaLR 0.11, Uncertain significance, Inborn genetic diseases; Combined immunodeficiency due to DOCK8 deficiency
- P5S (p.Pro5Ser), gnomAD 9-214989-C-T, AlphaMissense 0.12, MetaLR 0.02
- P5T (p.Pro5Thr), gnomAD 9-214989-C-A, AlphaMissense 0.16, MetaLR 0.03
- P5Q (p.Pro5Gln), gnomAD 9-214990-C-A, AlphaMissense 0.30, MetaLR 0.05
- P5P (p.Pro5Pro), rs148276394, gnomAD 9-214991-G-A, MetaLR 0.05, MetaSVM -0.94
- S6G (p.Ser6Gly), Ensembl rs2131308978
- S6I (p.Ser6Ile), rs756971694, ClinGen CA372755560, ClinVar RCV006466540, ExAC rs756971694, MetaLR 0.02, MetaSVM -0.98, Uncertain significance, Inborn genetic diseases; Combined immunodeficiency due to DOCK8 deficiency
- S6N (p.Ser6Asn), ExAC rs756971694, TOPMed rs756971694, gnomAD rs756971694, MetaLR 0.02, MetaSVM -0.99, Uncertain significance
- S6R (p.Ser6Arg), gnomAD rs1478022070, MetaLR 0.02, MetaSVM -0.97, Likely benign
- S6T (p.Ser6Thr), ExAC rs756971694, TOPMed rs756971694, gnomAD rs756971694, MetaLR 0.02, MetaSVM -0.97, Uncertain significance
- S6S (p.Ser6Ser), rs1478022070, gnomAD 9-214994-C-T, MetaLR 0.03, MetaSVM -1.05
- A7T (p.Ala7Thr), gnomAD 9-214995-G-A, AlphaMissense 0.17, MetaLR 0.02
- A7S (p.Ala7Ser), gnomAD 9-214995-G-T, AlphaMissense 0.09, MetaLR 0.04
- A7P (p.Ala7Pro), gnomAD 9-214995-G-C, AlphaMissense 0.25, MetaLR 0.05
- A7A (p.Ala7Ala), gnomAD 9-214997-A-G, MetaLR 0.02, MetaSVM -1.00
- E8D (p.Glu8Asp), rs780984101, ClinGen CA4956908, ClinVar RCV004619508, ClinVar RCV005093376, AlphaMissense 0.12, MetaLR 0.05, Uncertain significance, Inborn genetic diseases
- E8G (p.Glu8Gly), gnomAD rs2046706273, AlphaMissense 0.58, MetaLR 0.03
- E8K (p.Glu8Lys), rs1188948475, ClinGen CA372755608, ClinVar RCV006466389, gnomAD rs1188948475, AlphaMissense 0.89, MetaLR 0.02, Uncertain significance, Combined immunodeficiency due to DOCK8 deficiency
- E8Q (p.Glu8Gln), gnomAD 9-214998-G-C, AlphaMissense 0.55, MetaLR 0.02
- E8* (p.Glu8Ter), gnomAD 9-214998-G-T, CADD 46.00
- E8V (p.Glu8Val), gnomAD 9-214999-A-T, AlphaMissense 0.82, MetaLR 0.06
- E8E (p.Glu8Glu), rs780984101, gnomAD 9-215000-G-A, MetaLR 0.03, MetaSVM -1.07
- R9C (p.Arg9Cys), gnomAD 9-215001-C-T, AlphaMissense 0.97, MetaLR 0.05
- R9S (p.Arg9Ser), gnomAD 9-215001-C-A, AlphaMissense 0.98, MetaLR 0.03
- R9G (p.Arg9Gly), gnomAD 9-215001-C-G, AlphaMissense 0.90, MetaLR 0.03
- R9H (p.Arg9His), gnomAD 9-215002-G-A, MetaLR 0.03, MetaSVM -1.04
- R9L (p.Arg9Leu), gnomAD 9-215002-G-T, MetaLR 0.03, MetaSVM -1.00
- R9R (p.Arg9Arg), rs1465766530, gnomAD 9-215003-C-A, MetaLR 0.06, MetaSVM -1.06
- R10C (p.Arg10Cys), TOPMed rs1448715670, gnomAD rs1448715670, AlphaMissense 0.97, MetaLR 0.05
- R10L (p.Arg10Leu), gnomAD rs1233947697, MetaLR 0.03, MetaSVM -1.08
- R10S (p.Arg10Ser), gnomAD 9-215004-C-A, AlphaMissense 0.99, MetaLR 0.04
- R10G (p.Arg10Gly), gnomAD 9-215004-C-G, AlphaMissense 0.93, MetaLR 0.05
- R10H (p.Arg10His), gnomAD 9-215005-G-A, MetaLR 0.04, MetaSVM -1.07
- R10P (p.Arg10Pro), gnomAD 9-215005-G-C, MetaLR 0.04, MetaSVM -1.09
- R10R (p.Arg10Arg), gnomAD 9-215006-C-G, MetaLR 0.04, MetaSVM -1.08
- A11E (p.Ala11Glu), Ensembl rs2046706663, AlphaMissense 0.90, MetaLR 0.05
- A11P (p.Ala11Pro), ExAC rs745702582, gnomAD rs745702582, AlphaMissense 0.90, MetaLR 0.06
- A11T (p.Ala11Thr), gnomAD 9-215007-G-A, AlphaMissense 0.86, MetaLR 0.05
- A11G (p.Ala11Gly), gnomAD 9-215008-C-G, AlphaMissense 0.59, MetaLR 0.06
- A11V (p.Ala11Val), gnomAD 9-215008-C-T, AlphaMissense 0.89, MetaLR 0.07
- A11A (p.Ala11Ala), gnomAD 9-215009-G-C, MetaLR 0.02, MetaSVM -1.02
- F12L (p.Phe12Leu), rs566738926, ClinGen CA4956910, ClinVar RCV000332616, 1000Genomes rs566738926, CADD 43.00, PolyPhen-2 0.00, Conflicting interpretations, Combined immunodeficiency due to DOCK8 deficiency
- F12V (p.Phe12Val), rs886063779, ClinGen CA10633224, ClinVar RCV000296274, TOPMed rs886063779, MetaLR 0.03, MetaSVM -1.09, Uncertain significance, Combined immunodeficiency due to DOCK8 deficiency
- F12Y (p.Phe12Tyr), gnomAD 9-215011-T-A, MetaLR 0.03, MetaSVM -1.09
- F12S (p.Phe12Ser), gnomAD 9-215011-T-C, MetaLR 0.03, MetaSVM -1.09
- A13P (p.Ala13Pro), rs749272308, ClinGen CA4956912, ClinVar RCV004980398, ClinVar RCV005416526, AlphaMissense 0.94, MetaLR 0.05, Uncertain significance, Hyper-IgE recurrent infection syndrome 3, autosomal recessive; Inborn genetic di
- A13T (p.Ala13Thr), NCI-TCGA Cosmic COSV6668, Uncertain significance, Inborn genetic diseases
- A13V (p.Ala13Val), ExAC rs768525450, TOPMed rs768525450, gnomAD rs768525450, AlphaMissense 0.30, MetaLR 0.02
- A13E (p.Ala13Glu), gnomAD 9-215014-C-A, AlphaMissense 0.97, MetaLR 0.03
- A13A (p.Ala13Ala), rs773286453, gnomAD 9-215015-G-A, MetaLR 0.03, MetaSVM -1.05
- L14F (p.Leu14Phe), rs1273096402, ClinGen CA372755763, ClinVar RCV005416461, TOPMed rs1273096402, AlphaMissense 0.23, MetaLR 0.03, Uncertain significance, Hyper-IgE recurrent infection syndrome 3, autosomal recessive
- L14I (p.Leu14Ile), gnomAD 9-215016-C-A, MetaLR 0.02, MetaSVM -1.03
- L14P (p.Leu14Pro), gnomAD 9-215017-T-C, MetaLR 0.02, MetaSVM -1.00
- L14L (p.Leu14Leu), gnomAD 9-215018-C-A, CADD 42.00
- K15N (p.Lys15Asn), Ensembl rs2046707186, AlphaMissense 0.96, MetaLR 0.04
- K15Q (p.Lys15Gln), rs1219439848, ClinGen CA372755781, ClinVar RCV005416668, TOPMed rs1219439848, AlphaMissense 0.69, MetaLR 0.05, Uncertain significance, Hyper-IgE recurrent infection syndrome 3, autosomal recessive
- K15R (p.Lys15Arg), ExAC rs771201533, TOPMed rs771201533, gnomAD rs771201533, AlphaMissense 0.14, MetaLR 0.06
- K15M (p.Lys15Met), gnomAD 9-215020-A-T, AlphaMissense 0.91, MetaLR 0.07
- I16F (p.Ile16Phe), TOPMed rs1383917572
- I16M (p.Ile16Met), TOPMed rs1316350320, gnomAD rs1316350320, MetaLR 0.02, MetaSVM -1.03
- I16T (p.Ile16Thr), gnomAD 9-215023-T-C, MetaLR 0.02, MetaSVM -1.03
- I16I (p.Ile16Ile), rs1316350320, gnomAD 9-215024-C-A, MetaLR 0.06, MetaSVM -1.00
- N17D (p.Asn17Asp), rs776889811, ClinGen CA372755831, ClinVar RCV005555023, ClinVar RCV006563668, AlphaMissense 0.63, MetaLR 0.03, Uncertain significance, Inborn genetic diseases; Combined immunodeficiency due to DOCK8 deficiency
- N17S (p.Asn17Ser), rs1291124124, ClinGen CA372755839, ClinVar RCV006559576, gnomAD rs1291124124, AlphaMissense 0.09, MetaLR 0.04, Uncertain significance, Combined immunodeficiency due to DOCK8 deficiency
- N17Y (p.Asn17Tyr), rs776889811, ClinGen CA4956917, ClinVar RCV006465195, ExAC rs776889811, AlphaMissense 0.61, MetaLR 0.03, Uncertain significance, Combined immunodeficiency due to DOCK8 deficiency
- N17T (p.Asn17Thr), gnomAD 9-215023-TC-T, CADD 32.00
- N17N (p.Asn17Asn), gnomAD 9-215027-C-T, MetaLR 0.06, MetaSVM -1.01
- N17K (p.Asn17Lys), gnomAD 9-215027-C-A, AlphaMissense 0.88, MetaLR 0.06
- R18G (p.Arg18Gly), rs200689054, ClinGen CA4956918, ClinVar RCV000494317, ClinVar RCV000624829, AlphaMissense 0.92, MetaLR 0.04, Conflicting interpretations, not provided; Inborn genetic diseases; Combined immunodeficiency due to DOCK8 de
- R18K (p.Arg18Lys), rs1197388365, ClinGen CA372755865, ClinVar RCV005057725, TOPMed rs1197388365, MetaLR 0.01, MetaSVM -1.02, Uncertain significance
- R18W (p.Arg18Trp), gnomAD 9-215028-A-T, AlphaMissense 0.96, MetaLR 0.05
- R18M (p.Arg18Met), gnomAD 9-215029-G-T, MetaLR 0.02, MetaSVM -1.05
- R18R (p.Arg18Arg), rs2048167738, gnomAD 9-271627-G-A, CADD 22.90
- Y19C (p.Tyr19Cys), rs578093992, ClinGen CA372752176, ClinVar RCV005238164, ClinVar RCV006468862, AlphaMissense 0.14, MetaLR 0.03, Uncertain significance, Combined immunodeficiency due to DOCK8 deficiency; not specified
- Y19F (p.Tyr19Phe), TOPMed rs578093992, gnomAD rs578093992, AlphaMissense 0.09, MetaLR 0.03, Uncertain significance
- Y19Y (p.Tyr19Tyr), rs2048167841, gnomAD 9-271630-T-C, CADD 6.74
- S20F (p.Ser20Phe), rs1363190971, ClinGen CA372752188, ClinVar RCV005058937, TOPMed rs1363190971, AlphaMissense 0.56, MetaLR 0.07, Uncertain significance
- S20T (p.Ser20Thr), rs2537455736, ClinGen CA372752183, ClinVar RCV006560676, AlphaMissense 0.10, MetaLR 0.04, Uncertain significance, Combined immunodeficiency due to DOCK8 deficiency
- S20Y (p.Ser20Tyr), gnomAD 9-271632-C-A, AlphaMissense 0.50, MetaLR 0.07
- S20S (p.Ser20Ser), rs966158643, gnomAD 9-271633-T-C, CADD 10.30
- S21L (p.Ser21Leu), 1000Genomes rs2129939906, AlphaMissense 0.47, MetaLR 0.04
- S21T (p.Ser21Thr), Ensembl rs1328229742
- A22E (p.Ala22Glu), 1000Genomes rs506121, ESP rs506121, ExAC rs506121, TOPMed rs506121, Benign
- A22T (p.Ala22Thr), Ensembl rs138659571
- A22V (p.Ala22Val), rs506121, ClinGen CA175834, ClinVar RCV000150504, ClinVar RCV000210052, AlphaMissense 0.30, MetaLR 0.00, Benign/Likely benign, not specified; not provided; Combined immunodeficiency due to DOCK8 deficiency
- A22P (p.Ala22Pro), gnomAD 9-271637-G-C, AlphaMissense 0.73, MetaLR 0.06
- A22A (p.Ala22Ala), rs561397821, gnomAD 9-271639-G-T, CADD 7.82
- E23* (p.Glu23Ter), gnomAD rs1380294732
- E23E (p.Glu23Glu), gnomAD 9-271642-A-G, CADD 9.38
- I24M (p.Ile24Met), rs531628086, ClinGen CA10633334, ClinVar RCV000350034, 1000Genomes rs531628086, AlphaMissense 0.23, MetaLR 0.04, Uncertain significance, Combined immunodeficiency due to DOCK8 deficiency
- I24V (p.Ile24Val), gnomAD 9-271643-A-G, AlphaMissense 0.15, MetaLR 0.01
- I24R (p.Ile24Arg), gnomAD 9-271644-T-G, AlphaMissense 0.87, MetaLR 0.05
- R25G (p.Arg25Gly), rs1026518997, ClinGen CA187758056, ClinVar RCV006468946, Ensembl rs1026518997, AlphaMissense 0.93, MetaLR 0.11, Uncertain significance, Combined immunodeficiency due to DOCK8 deficiency
- R25S (p.Arg25Ser), gnomAD 9-271648-G-T, AlphaMissense 0.99, MetaLR 0.09
- K26E (p.Lys26Glu), gnomAD rs2048168392, AlphaMissense 0.66, MetaLR 0.06, Uncertain significance
- K26N (p.Lys26Asn), ESP rs369163495, TOPMed rs369163495, gnomAD rs369163495, AlphaMissense 0.83, MetaLR 0.04
- K26Q (p.Lys26Gln), rs2048168392, ClinGen CA372752257, ClinVar RCV006563888, gnomAD rs2048168392, AlphaMissense 0.27, MetaLR 0.06, Uncertain significance, Combined immunodeficiency due to DOCK8 deficiency
- K26R (p.Lys26Arg), gnomAD 9-271650-A-G, AlphaMissense 0.07, MetaLR 0.02
- K26K (p.Lys26Lys), rs369163495, gnomAD 9-271651-A-G, CADD 8.38
- Q27H (p.Gln27His), rs1322181469, ClinGen CA372752280, ClinVar RCV006468841, TOPMed rs1322181469, AlphaMissense 0.16, MetaLR 0.02, Uncertain significance, Combined immunodeficiency due to DOCK8 deficiency
- Q27K (p.Gln27Lys), ExAC rs748215543, gnomAD rs748215543, AlphaMissense 0.18, MetaLR 0.05
- F28I (p.Phe28Ile), Ensembl rs1563857653, AlphaMissense 0.21, MetaLR 0.02
- F28L (p.Phe28Leu), rs2048168645, ClinGen CA372752302, ClinVar RCV001349588, ClinVar RCV002545614, AlphaMissense 0.80, MetaLR 0.02, Uncertain significance, Inborn genetic diseases; Combined immunodeficiency due to DOCK8 deficiency
- F28Y (p.Phe28Tyr), gnomAD 9-271654-GTT-G, CADD 27.20
- L30V (p.Leu30Val), gnomAD rs1245164919, AlphaMissense 0.06, MetaLR 0.03
- L30I (p.Leu30Ile), gnomAD 9-271661-C-A, AlphaMissense 0.07, MetaLR 0.03
- L30L (p.Leu30Leu), rs1291085702, gnomAD 9-271663-C-G, CADD 4.08
- P31S (p.Pro31Ser), gnomAD 9-271664-C-T, AlphaMissense 0.08, MetaLR 0.02
- P31L (p.Pro31Leu), gnomAD 9-271665-C-T, AlphaMissense 0.08, MetaLR 0.03
- P32S (p.Pro32Ser), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- P32A (p.Pro32Ala), gnomAD 9-271667-C-G, AlphaMissense 0.07, MetaLR 0.03
- N33Y (p.Asn33Tyr), gnomAD 9-271670-A-T, AlphaMissense 0.09, MetaLR 0.03
- Q36E (p.Gln36Glu), TOPMed rs2048168863
- H38R (p.His38Arg), TOPMed rs985067218, gnomAD rs985067218, AlphaMissense 0.07, MetaLR 0.03, Uncertain significance, Inborn genetic diseases
- R39* (p.Arg39Ter), rs1262383526, NCI-TCGA Cosmic COSV6663, TOPMed rs1262383526, gnomAD rs1262383526, CADD 43.00, Variant assessed as somatic; high impact.
- R39P (p.Arg39Pro), TOPMed rs909479628, gnomAD rs909479628, AlphaMissense 0.19, MetaLR 0.03
- R39Q (p.Arg39Gln), TOPMed rs909479628, gnomAD rs909479628, AlphaMissense 0.07, MetaLR 0.03
- R39S (p.Arg39Ser), rs980203348, []
- Q40* (p.Gln40Ter), Ensembl rs2048169062, CADD 40.00
- S41G (p.Ser41Gly), TOPMed rs1326519555, gnomAD rs1326519555, AlphaMissense 0.09, MetaLR 0.04
- S41I (p.Ser41Ile), TOPMed rs1264607684, gnomAD rs1264607684, AlphaMissense 0.16, MetaLR 0.05
- I42L (p.Ile42Leu), rs1485703434, ClinGen CA372752394, ClinVar RCV005209405, TOPMed rs1485703434, AlphaMissense 0.06, MetaLR 0.02, Uncertain significance
- I42M (p.Ile42Met), rs962341270, ClinGen CA372752400, ClinVar RCV006559670, Uncertain significance, Combined immunodeficiency due to DOCK8 deficiency
- I42R (p.Ile42Arg), gnomAD rs1185078111, AlphaMissense 0.13, MetaLR 0.03
- I42V (p.Ile42Val), TOPMed rs1485703434, gnomAD rs1485703434, AlphaMissense 0.06, MetaLR 0.02, Uncertain significance
- S43G (p.Ser43Gly), rs2537456155, ClinGen CA372752403, ClinVar RCV005096118, AlphaMissense 0.08, MetaLR 0.04, Uncertain significance
- S45C (p.Ser45Cys), ExAC rs772334083, TOPMed rs772334083, gnomAD rs772334083, AlphaMissense 0.08, MetaLR 0.08
- G46D (p.Gly46Asp), rs758437810, ClinGen CA187758124, ClinVar RCV005416641, ClinVar RCV005433242, AlphaMissense 0.22, MetaLR 0.03, Conflicting interpretations, Severe combined immunodeficiency disease; Hyper-IgE recurrent infection syndrome
- S49T (p.Ser49Thr), TOPMed rs1327487790
- L50F (p.Leu50Phe), rs1045835531, ClinGen CA187758129, ClinVar RCV003433008, ClinVar RCV005328519, AlphaMissense 0.07, MetaLR 0.02, Uncertain significance, not provided; Hyper-IgE recurrent infection syndrome 3, autosomal recessive; Inb
- L50V (p.Leu50Val), TOPMed rs1045835531, gnomAD rs1045835531, AlphaMissense 0.07, MetaLR 0.02, Uncertain significance
- Q51* (p.Gln51Ter), TOPMed rs1420962244, gnomAD rs1420962244, CADD 43.00, Uncertain significance
- Q51E (p.Gln51Glu), rs1420962244, ClinGen CA372752452, ClinVar RCV006562704, TOPMed rs1420962244, AlphaMissense 0.10, MetaLR 0.03, Uncertain significance, Combined immunodeficiency due to DOCK8 deficiency
- Q51R (p.Gln51Arg), gnomAD rs1158781902, AlphaMissense 0.11, MetaLR 0.04
- P53L (p.Pro53Leu), ExAC rs777781052, TOPMed rs777781052, gnomAD rs777781052, AlphaMissense 0.21, MetaLR 0.03, Uncertain significance
- P53R (p.Pro53Arg), rs777781052, ClinGen CA372755698, ClinVar RCV006468476, ExAC rs777781052, AlphaMissense 0.21, MetaLR 0.03, Uncertain significance, Combined immunodeficiency due to DOCK8 deficiency
- Q54H (p.Gln54His), 1000Genomes rs190478517, AlphaMissense 0.12, MetaLR 0.03
- Q54R (p.Gln54Arg), gnomAD rs2048827572, AlphaMissense 0.10, MetaLR 0.03
- Y56C (p.Tyr56Cys), rs373301364, ClinGen CA4957126, ClinVar RCV004972967, ClinVar RCV005092404, AlphaMissense 0.15, MetaLR 0.03, Uncertain significance, Inborn genetic diseases
- P58H (p.Pro58His), 1000Genomes rs181739250, ESP rs181739250, ExAC rs181739250, TOPMed rs181739250, AlphaMissense 0.34, MetaLR 0.05
- P58L (p.Pro58Leu), 1000Genomes rs181739250, ESP rs181739250, ExAC rs181739250, TOPMed rs181739250, AlphaMissense 0.15, MetaLR 0.02
- P58R (p.Pro58Arg), 1000Genomes rs181739250, ESP rs181739250, ExAC rs181739250, TOPMed rs181739250
- P58T (p.Pro58Thr), ExAC rs777118726, gnomAD rs777118726, AlphaMissense 0.09, MetaLR 0.03
- V59L (p.Val59Leu), TOPMed rs955740785, gnomAD rs955740785, AlphaMissense 0.37, MetaLR 0.09
- V59M (p.Val59Met), TOPMed rs955740785, gnomAD rs955740785, AlphaMissense 0.30, MetaLR 0.15
- E60* (p.Glu60Ter), 1000Genomes rs1472799765, gnomAD rs1472799765, CADD 42.00
- E60D (p.Glu60Asp), rs370107163, ClinGen CA4957131, ClinVar RCV001816840, ClinVar RCV004027399, AlphaMissense 0.10, MetaLR 0.05, Uncertain significance, not specified; Hyper-IgE recurrent infection syndrome 3, autosomal recessive; In
- E60V (p.Glu60Val), rs760312255, ClinGen CA187775406, ClinVar RCV006562763, Ensembl rs760312255, AlphaMissense 0.16, MetaLR 0.15, Uncertain significance, Combined immunodeficiency due to DOCK8 deficiency
- P61A (p.Pro61Ala), Ensembl rs2048828543
- V62G (p.Val62Gly), rs1360426782, ClinGen CA372755917, ClinVar RCV006471870, TOPMed rs1360426782, AlphaMissense 0.23, MetaLR 0.04, Uncertain significance, Combined immunodeficiency due to DOCK8 deficiency
- D63E (p.Asp63Glu), TOPMed rs2048828820, Likely benign
- D63N (p.Asp63Asn), rs3209441, ClinGen CA175837, ClinVar RCV000150505, ClinVar RCV000276708, AlphaMissense 0.26, MetaLR 0.00, Benign/Likely benign, not specified; not provided; Combined immunodeficiency due to DOCK8 deficiency
- F64L (p.Phe64Leu), Ensembl rs2048828894, AlphaMissense 0.74, MetaLR 0.02
- G66R (p.Gly66Arg), rs750973745, ClinGen CA4957133, ClinVar RCV003044226, ExAC rs750973745, AlphaMissense 0.29, MetaLR 0.03, Uncertain significance, Combined immunodeficiency due to DOCK8 deficiency
- L67F (p.Leu67Phe), ExAC rs761529046, TOPMed rs761529046, gnomAD rs761529046, AlphaMissense 0.08, MetaLR 0.01
- L68M (p.Leu68Met), rs980203348, ClinGen CA187775428, ClinVar RCV004973459, ClinVar RCV006471500, AlphaMissense 0.15, MetaLR 0.07, Uncertain significance, Inborn genetic diseases; Combined immunodeficiency due to DOCK8 deficiency
- M69I (p.Met69Ile), TOPMed rs1477904401
- M69L (p.Met69Leu), gnomAD rs2048829373
- T70I (p.Thr70Ile), TOPMed rs1019319527, gnomAD rs1019319527
- T70R (p.Thr70Arg), TOPMed rs1019319527, gnomAD rs1019319527, REVEL 0.10, AlphaMissense 0.15
- H71D (p.His71Asp), TOPMed rs1444485949, gnomAD rs1444485949
- H71N (p.His71Asn), TOPMed rs1444485949, gnomAD rs1444485949, REVEL 0.11, AlphaMissense 0.09
- N73K (p.Asn73Lys), TOPMed rs1280004562, gnomAD rs1280004562, REVEL 0.05, AlphaMissense 0.16, Uncertain significance, Inborn genetic diseases
- N73S (p.Asn73Ser), rs886063849, ClinGen CA10627201, ClinVar RCV000308403, ClinVar RCV005416339, REVEL 0.05, AlphaMissense 0.07, Uncertain significance, Combined immunodeficiency due to DOCK8 deficiency; Hyper-IgE recurrent infection
- S74I (p.Ser74Ile), rs563918671, ClinGen CA372756113, ClinVar RCV004621754, ClinVar RCV006473598, AlphaMissense 0.07, MetaLR 0.05, Uncertain significance, Inborn genetic diseases; Combined immunodeficiency due to DOCK8 deficiency
- S74N (p.Ser74Asn), 1000Genomes rs563918671, ExAC rs563918671, TOPMed rs563918671, gnomAD rs563918671, REVEL 0.07, AlphaMissense 0.07, Uncertain significance
- S74T (p.Ser74Thr), rs563918671, 1000Genomes rs563918671, ExAC rs563918671, TOPMed rs563918671, REVEL 0.05, AlphaMissense 0.08, Uncertain significance
- L75V (p.Leu75Val), rs368133450, ClinGen CA4957137, ClinVar RCV001046845, ClinVar RCV003151273, REVEL 0.03, AlphaMissense 0.08, Uncertain significance, Inborn genetic diseases; Combined immunodeficiency due to DOCK8 deficiency
- D76E (p.Asp76Glu), Ensembl rs2048830356
Public DOCK8 analysis runs
- DOCK8 analysis run — DOCK8 (3,055 variants) — completed 2026-08-21